Smoking cessation drug effective for women faster than men
Created 10/07/2015 - 09:41
- Research data published in the journal Nicotine and Tobacco Research reveal that Chantix is more effective in women than in men during the first year of treatment, as reported Breitbart Wednesday.
- Other nicotine replacement therapies and drugs such as Wellbutrin and Zyban have generally been more effective in men than in women, while researchers have hypothesised that the nicotine receptor system in the brain may work differently between men and women.
- In the study, the researchers analysed 17 clinical studies in which smokers were randomised to treatment with Chantix or placebo.
- The investigators found that after adjusting for the lower effect of placebo in women, Chantix was 46 percent more effective in helping women quit than men and 31 percent more effective in maintaining complete abstinence in women after six months.
- However, the researchers noted that the drug was similarly effective in men and women after one year.
- "This is the first demonstration that women compared to men have a preferred therapeutic response for a smoking cessation medication when considering short-term treatment outcomes and equal outcomes at one year," McKee remarked, adding "[Chantix] appears to be particularly useful for reducing the sex disparity in smoking cessation rates."